Establishing the performance and acceptability of dried blood spot sampling to screen for islet‐specific autoantibodies
DBS sampling can be used as an alternative to serum for use with the 3-screen assay for general population type 1 diabetes autoantibody screening. DBS sampling appears acceptable to parents and stakeholders.
Authors
- Ian Litchfield (ORCID: https://orcid.org/0000-0002-1169-5392)
- Sheila Greenfield (ORCID: https://orcid.org/0000-0002-8796-4114)
- Lauren M. Quinn (ORCID: https://orcid.org/0000-0003-0500-4417)
- Sian Faustini (ORCID: https://orcid.org/0000-0002-9300-5569)
- Christopher Bentley (ORCID: https://orcid.org/0000-0002-8099-2024)
- Alex Richter (ORCID: https://orcid.org/0000-0003-2885-1299)
- Siobhan K. Young
- Madeeha Hoque
- Parth Narendran (ORCID: https://orcid.org/0000-0002-4583-8793)
- Timothy Plant (ORCID: https://orcid.org/0000-0003-1816-206X)
- Felicity Boardman (ORCID: https://orcid.org/0000-0002-3268-6276)
- H.F. Kwok
Institutions
- University College Birmingham (GB)
- University of Warwick (GB)
- University of Birmingham (GB)
Publication Details
- Journal
- Diabetic Medicine
- Published
- 2025-05-19
- DOI
- https://doi.org/10.1111/dme.70071
- Citations
- 3
- Primary Topic
- Diabetes and associated disorders
- Type
- article
- Field-Weighted Citation Impact
- 5.45
Funders
- National Institute for Health and Care Research
- Diabetes UK